Stockscreener 앱 받기
1.3764
6.15%
0.0764
Akebia Therapeutics Inc 주식(AKBA)의 최신 뉴스
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
AKBA Reiterates by HC Wainwright & Co. -- Price Target Maintained at $6.00 - GuruFocus
Akebia Therapeutics (AKBA) CFO sells 56K shares in tax sell-to-cover - Stock Titan
H.C. Wainwright reiterates Akebia stock rating on trial results By Investing.com - Investing.com Canada
Akebia TherapeuticsVoice Trial Meets Stopp - Moomoo
U.S. Renal Care and Akebia Therapeutics, Inc. Announce Interim Analysis of VOICE Trial Demonstrates Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo Versus ESA - marketscreener.com
Akebia Therapeutics, Inc. (AKBA) Strengthens Vafseo Patent Protection Through 2036 - Yahoo Finance
Akebia (AKBA) VOICE Trial Halted Following Positive Interim Resu - GuruFocus
Akebia Therapeutics, US Renal Care Halt Kidney Disease Trial After Positive Interim Analysis - marketscreener.com
Akebia: VOICE trial stopped early after vadadustat shows superiority on primary composite endpoint - TradingView
U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA - marketscreener.com
Vafseo trial stops early after safety win in dialysis patients - Stock Titan
Form 144 Akebia Therapeutics For: 29 June By Investing.com - Investing.com Australia
Akebia Therapeutics (AKBA) lists 56,019 shares after RSU vesting on 06/28/2026 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akebia Therap - The National Law Review
12 Best Low-Priced Pharma Stocks to Buy Right Now - Insider Monkey
AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction - Stocktwits
Price to book forward of Akebia Therapeutics, Inc. – NASDAQ:AKBA - TradingView
Enterprise value to EBIT forward of Akebia Therapeutics, Inc. – NASDAQ:AKBA - TradingView
Price to sales forward of Akebia Therapeutics, Inc. – NASDAQ:AKBA - TradingView
Akebia Therapeutics, Inc. Actuals & Estimates (NASDAQ:AKBA) - TradingView
AKBA Forecast — Price Target — Prediction for 2027 - TradingView
Akebia Therapeutics And 2 Other Promising Penny Stocks To Watch - Sahm
Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
Akebia Therapeutics 8-K Filing: June 2026 Shareholder Vote Results & Company Details - Minichart
Form 4 Akebia Ther For: 22 June By Investing.com - Investing.com Nigeria
Form 8K Akebia Ther For: 22 June By Investing.com - Investing.com Australia
Akebia (NASDAQ: AKBA) director Myles Wolf granted RSUs and options - Stock Titan
Akebia (AKBA) director Cynthia Smith granted RSUs and options for board service - Stock Titan
Akebia Therapeutics (AKBA) grants RSUs and stock options to director Rogers - Stock Titan
[Form 4] Akebia Therapeutics, Inc. Insider Trading Activity - Stock Titan
Akebia Therapeutics (NASDAQ: AKBA) investors back share increase and executive pay - Stock Titan
Akebia Therapeutics (AKBA) director receives RSU and stock option grants - Stock Titan
Akebia Therapeutics (AKBA) awards RSUs and stock options to director Adams - Stock Titan
Akebia Therapeutics, Inc.(NasdaqCM:AKBA) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Q1 2026 Akebia Therapeutics Inc Earnings Call Transcript - GuruFocus
Akebia Therapeutics Inc (AKBA) Institutional Confidence - TradingKey
Akebia Therapeutics Inc (AKBA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Akebia Therapeutics Inc (AKBA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Akebia Therapeutics Inc (AKBA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Akebia Therapeutics Inc (AKBA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Akebia Therapeutics Inc (AKBA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Akebia Therapeutics (AKBA) AGM 2026 Summary - Quartr
AKBA: All proposals passed, including director elections and share authorization increase - TradingView
Akebia Therapeutics Inc (AKBA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AKBA: All proposals, including director elections and share increases, were approved by stockholders - TradingView
Akebia Therapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus
Akebia Therapeutics Inc (AKBA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Akebia Therapeutics Inc (AKBA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
0.15%
1.42%
자본화:
|
볼륨(24시간):